International Clinical Trial: A single-arm, multicenter phase II clinical study of venetoclax combined with liposomal mitoxantrone and cytarabine as induction therapy in young patients with acute myeloid leukemia (AML)

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129103) titled 'A single-arm, multicenter phase II clinical study of venetoclax combined with liposomal mitoxantrone and cytarabine as induction therapy in young patients with acute myeloid leukemia (AML)' on July 31.

Study Type: Observational study

Study Design: Single arm

Primary Sponsor: HenanCancerHospital

Condition: Acute Myeloid Leukemia

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2025-12-06

Target Sample Size: Trail Group:32;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=315962

Published by HT Digital Content Services with permission f...